3E Bioventures Capital
Life science VC investing in biotech and techbio innovators
About This Fund
3E Bioventures Capital is an institutional investor (Conventional VCs) founded in 2015 and headquartered in Beijing, china (and 2 other locations). Life science VC investing in biotech and techbio innovators. The firm focuses on investing in global leading health innovators within the biotech and techbio sectors. They target new drugs, new modalities, and drug discovery platforms, as well as the intersection of biology and technology. With a science-driven and entrepreneur-friendly investment philosophy, they collaborate closely with companies and research institutions to develop drugs or products addressing significant unmet medical needs. Their approach emphasizes expertise, efficiency, and execution, aiming to drive success in the life science industry. They are actively seeking business plans from innovative ventures. Practice areas include Investment Industry. The firm operates as Venture Capital Funds. Key investment sectors include Healthcare / HealthTech and Biotech / Biopharma.
Investment Focus
Preparing to pitch 3E Bioventures Capital?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →